Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
62
CTNM Quote, Financials, Valuation and Earnings
Last price:
$12.34
Seasonality move
:
-24.83%
Day range:
$11.74 - $12.41
52-week range:
$3.35 - $15.25
Dividend yield:
0%
P/E ratio:
50.95x
P/S ratio:
--
P/B ratio:
1.76x
Volume:
139.5K
Avg. volume:
245.2K
1-year change:
-9.19%
Market cap:
$317.2M
Revenue:
--
EPS (TTM):
-$2.26
Earnings Data
Next earnings date for CTNM
Mar 05
2026
Most recent earnings per share
-$0.46
Beat by $0.00
(Oct 30/2025)
Consensus Estimate
-$0.46
(Oct 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTNM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 | $5M | -- | -- | -$0.39 | -- |
| 10/30/2025 | Q3 | $5M | -- | -$0.46 | -$0.46 | $0.00 |
| 08/13/2025 | Q2 | $6M | -- | -$0.62 | -$0.41 | -$0.21 |
| 05/15/2025 | Q1 | -- | -- | -$0.62 | -$0.57 | -$0.05 |
| 03/06/2025 | Q4 | -- | -- | -$0.56 | -$0.44 | -$0.13 |
| 11/06/2024 | Q3 | -- | -- | -- | -$0.43 | -- |
| 08/13/2024 | Q2 | -- | -- | -$0.39 | -$0.35 | -$0.04 |
| 03/31/2024 | Q1 | -- | -- | -$0.31 | -$1.33 | $1.02 |
| 12/31/2023 | Q4 | -- | -- | $0.68 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | $0.92 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.29 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.45 | -- | -- |
Contineum Therapeutics, Inc. Earnings Questions
-
How Much did Contineum Therapeutics, Inc. Generate in Revenue Last Quarter?
Contineum Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Contineum Therapeutics, Inc. Beat Earnings Last Quarter?
Contineum Therapeutics, Inc. announced earnings per share of -$0.46 which represents a beat of analyst forecast a -$0.46 per share.
-
Is Contineum Therapeutics, Inc. Profitable?
Contineum Therapeutics, Inc. reported -$81K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Contineum Therapeutics, Inc. EPS Next Year?
Contineum Therapeutics, Inc.'s earnings are forecast to decrease from -$1.63 per share to -$1.90 per share next year representing a decrease of -25.34%.
-
When is Contineum Therapeutics, Inc.'s Earnings Date?
Contineum Therapeutics, Inc.'s next earnings date is March 5, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is down 0.27% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
